Evidence map›Paper›PMID 41904651›Full record

ArticleEuropean heart journal. Cardiovascular Imaging2026

Smoking cessation after first STEMI enhances infarct healing: a cardiac MRI study.

Felix Troger, Mathias Pamminger, Martin Reindl, Ivan Lechner, Christina Tiller, Alex Kaser, Philip Lungenschmid, Matthias Schwab, Bernhard Metzler, Sebastian J Reinstadler and 1 more

Abstract read
In one paragraph

Article in European heart journal. Cardiovascular Imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Felix TrogerUniversity Clinic of Radiology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.ORCID 0000-0002-0401-5045
Mathias PammingerUniversity Clinic of Radiology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.ORCID 0000-0001-9241-6334
Martin ReindlUniversity Clinic of Internal Medicine III, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.
Ivan LechnerUniversity Clinic of Internal Medicine III, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.ORCID 0000-0003-1379-3233
Christina TillerUniversity Clinic of Internal Medicine III, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.
Alex KaserUniversity Clinic of Internal Medicine III, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.
Philip LungenschmidUniversity Clinic of Radiology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.
Matthias SchwabUniversity Clinic of Radiology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.
Bernhard MetzlerUniversity Clinic of Internal Medicine III, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.
Sebastian J ReinstadlerUniversity Clinic of Internal Medicine III, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.
Agnes MayrUniversity Clinic of Radiology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.ORCID 0000-0001-9363-873X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsSmoking cessation represents an important step in primary and secondary prevention of myocardial infarction. While there are few data on the extent of initial myocardial damage in current smokers, there are hardly any data on the evolution of the infarct in active smokers and in patients giving up smoking. This prospective study investigated infarct dynamics in patients quitting smoking after ST-elevation myocardial infarction (STEMI). METHODS AND

resultsOverall, 672 revascularized first-time STEMI patients were included. Smoking behaviour was documented at baseline and after 4 months. Cardiac magnetic resonance imaging (CMR) was performed at baseline and after 4 and 12 months, including infarct characteristics evaluation. Major adverse cardiac events (MACE) comprised all-cause death and reinfarction within a median observation period of 3.4 years. Initially, 382 patients (57%) were active smokers, of whom 183 (48%) quit smoking after the infarction. There were no differences in initial infarct size; however, at follow-up CMR examinations, infarct size reduced more in the cessation group compared to continuing smokers (after 12 months: 62% vs. 47%, P < 0.001). Additionally, MACE occurred less often in quitters (4%vs. 12%, P = 0.005). In multivariable logistic regression, continuing smoking was predictive of reduced infarct healing; in multivariable Cox-regression, it was a marker for MACE, independent of traditional cardiovascular risk markers.

conclusionSmoking cessation after the first STEMI appears to be an important factor positively influencing infarct healing. Within the observation period, fewer patients died in the cessation group. In sum, these data provide another valuable argument for quitting smoking, even after an infarction had already occurred.

Indexed as

Magnetic Resonance Imaging, CineSmoking CessationST Elevation Myocardial InfarctionAgedCohort StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesRisk AssessmentTreatment Outcomecardiac MRIinfarct healingmyocardial infarctionsmoking cessation

Identifiers

PMID41904651
PMCPMC13222720

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.